This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001; 119:8S-21S.HirshJDalenJAndersonDRPollerLBusseyHAnsellJOral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic rangeChest.20011198S21S10.1378/chest.119.1_suppl.8SSearch in Google Scholar
Bell RG. Vitamin K and chemical carcinogenesis. Lancet. 1978; 1:1161.77457BellRG.Vitamin K and chemical carcinogenesisLancet.19781116110.1016/S0140-6736(78)90347-1Search in Google Scholar
Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest. 2001; 119:22S-38S.AnsellJHirshJDalenJBusseyHAndersonDPollerLManaging oral anticoagulant therapyChest.200111922S38S10.1378/chest.119.1_suppl.22SSearch in Google Scholar
Palareti G, Warfarin anticoagulation in children made easier. Thromb Res. 2006; 118:667-9.1631394910.1016/j.thromres.2005.09.015PalaretiGWarfarin anticoagulation in children made easierThromb Res.2006118667916313949Search in Google Scholar
Wessler S, Gitel SN. Warfarin. From bedside to bench. N Engl J Med. 1984; 311:645-52.10.1056/NEJM1984090631110076472343WesslerSGitelSN.Warfarin. From bedside to benchN Engl J Med.1984311645526472343Open DOISearch in Google Scholar
Busakornruangrat S, Chuansumrit A, Angchaisuksiri P, Sasanakul W, Kadekasem P. Frequencies of polymorphism associated with cytochrome p450 in Thais. Thai J Hematol Transf Med. 2006; 16:213-9.BusakornruangratSChuansumritAAngchaisuksiriPSasanakulWKadekasemP.Frequencies of polymorphism associated with cytochrome p450 in ThaisThai J Hematol Transf Med.2006162139Search in Google Scholar
Klamchuen S, Chuansumrit A, Angchaisuksiri P, Sasanakul W. Frequency of polymorphisms associated with VKORC1 gene in Thai blood donors and patients receiving warfarin. Thai J Hematol Transf Med. 2008; 18:307-13.KlamchuenSChuansumritAAngchaisuksiriPSasanakulW.Frequency of polymorphisms associated with VKORC1 gene in Thai blood donors and patients receiving warfarinThai J Hematol Transf Med.20081830713Search in Google Scholar
Sangviroon A, Panomvana D, Tassaneeyakul W, Namchaisiri J. Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin. Drug Metab Pharmacokinet. 2010; 25:531-8.10.2133/dmpk.DMPK-10-RG-05920930419SangviroonAPanomvanaDTassaneeyakulWNamchaisiriJ.Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarinDrug Metab Pharmacokinet.201025531820930419Open DOISearch in Google Scholar
Gaikwad T, Ghosh K, Shetty S. VKORC1 and CYP2C9 genotype distribution in Asian countries. Thromb Res. 2014; 134:537-44.10.1016/j.thromres.2014.05.02824908449GaikwadTGhoshKShettyS.VKORC1 and CYP2C9 genotype distribution in Asian countriesThromb Res.20141345374424908449Open DOISearch in Google Scholar
Kuanprasert S, Dettrairat S, Palacajornsuk P, Kunachiwa W, Phrommintikul A. Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in northern Thailand. J Med Assoc Thai. 2009; 92:1597-601.20043560KuanprasertSDettrairatSPalacajornsukPKunachiwaWPhrommintikulA.Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in northern ThailandJ Med Assoc Thai.2009921597601Search in Google Scholar
Sangkhathat S, Kusafuka T, Chengkriwate P, Patrapinyokul S, Sangthong B, Fukuzawa M. Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients. J Hum Genet. 2006; 51:1126-32.1700907210.1007/s10038-006-0064-7SangkhathatSKusafukaTChengkriwatePPatrapinyokulSSangthongBFukuzawaM.Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patientsJ Hum Genet.20065111263217009072Search in Google Scholar
Seng KC, Gin GG, Sangkar JV, Phipps ME. Frequency of cytochrome P450 2C9 (CYP2C9) alleles in three ethnic groups in Malaysia. Asia Pacific J Mol Biol Biotechnol. 2003; 11:83-91.SengKCGinGGSangkarJVPhippsME.Frequency of cytochrome P450 2C9 (CYP2C9) alleles in three ethnic groups in MalaysiaAsia Pacific J Mol Biol Biotechnol.2003118391Search in Google Scholar
Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism. 2006; 55:515-24.VerbraeckenJVan de HeyningPDe BackerWVan GaalL.Body surface area in normal-weight, overweight, and obese adultsA comparison study. Metabolism.2006555152410.1016/j.metabol.2005.11.00416546483Search in Google Scholar
Sermsathanasawadi N, Sritongsathian C, Pongrattanaman N, Praditsuktavorn B, Hongku K, Wongwanit C, et al. The influence of VKORC1 polymorphisms on warfarin doses in Thai patients with deep vein thrombosis. J Med Assoc Thai. 2015; 98:549-54.26219158SermsathanasawadiNSritongsathianCPongrattanamanNPraditsuktavornBHongkuKWongwanitCThe influence of VKORC1 polymorphisms on warfarin doses in Thai patients with deep vein thrombosisJ Med Assoc Thai.20159854954Search in Google Scholar
Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther. 2011; 90:625-9.10.1038/clpt.2011.18521900891JohnsonJAGongLWhirl-CarrilloMGageBFScottSASteinCMClinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosingClin Pharmacol Ther.2011906259318755021900891Open DOISearch in Google Scholar
